Making the undruggable druggable.
Salipro Biotech AB is a privately held biotech company focused on unlocking challenging drug targets for the development of next-generation therapeutics. Headquartered in Stockholm, Sweden, the company collaborates with global pharma and biotech companies to accelerate the discovery of novel drugs. For our own pipeline, we are striving to develop drugs toward targets that no one could access before.
The majority of drug targets are so-called membrane proteins; however, these targets are inherently unstable and challenging to investigate. Our proprietary Salipro® technology stabilizes membrane proteins in their native forms, enabling them to be employed in drug discovery programs for therapeutic antibodies, small molecule drugs and structure-based drug design.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Teknikringen 38a, Stockholm,114 28,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- salipro.com
- Keywords
- Membrane proteins, Lipids, Nanoparticles, Drug Discovery, Antibody Development, Structural Biology, cryo-EM, Ion channels, GPCRs, Transporters.
- HQ
- Stockholm
Salipro Biotech Ab Questions
Salipro Biotech Ab's website is salipro.com
Salipro Biotech Ab's LinkedIn profile is https://se.linkedin.com/company/salipro-biotech
Salipro Biotech Ab has
9 employees.
View email and phone details for 9
employees at Salipro Biotech Ab.
Salipro Biotech Ab's industry is
Biotechnology Research
Salipro Biotech Ab's top competitors are
Bioarctic,
Pelago Bioscience Ab,
Rarity Bioscience,
Ki Innovations Ab,
Aax Biotech Ab,
Molecular Attraction Ab,
Atlas Antibodies,
Boehringer Ingelheim,
Affibody Ab,
Symcel.
Salipro Biotech Ab's categories are Biotechnology Research
Salipro Biotech Ab's founding year is 2016
